YU40452B - Process for the elimination of contaminating impurities from clavulinic acid - Google Patents
Process for the elimination of contaminating impurities from clavulinic acidInfo
- Publication number
- YU40452B YU40452B YU290/76A YU29076A YU40452B YU 40452 B YU40452 B YU 40452B YU 290/76 A YU290/76 A YU 290/76A YU 29076 A YU29076 A YU 29076A YU 40452 B YU40452 B YU 40452B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- elimination
- contaminating impurities
- clavulinic acid
- clavulinic
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB540975A GB1543563A (en) | 1975-02-07 | 1975-02-07 | Beta-lactam antibiotic in purified form |
GB1107675 | 1975-03-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
YU29076A YU29076A (en) | 1982-08-31 |
YU40452B true YU40452B (en) | 1986-02-28 |
Family
ID=26239868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU290/76A YU40452B (en) | 1975-02-07 | 1976-02-06 | Process for the elimination of contaminating impurities from clavulinic acid |
Country Status (15)
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ177159A (en) * | 1974-04-20 | 1978-03-06 | Beecham Group Ltd | Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions |
GB1542405A (en) * | 1975-04-15 | 1979-03-21 | Beecham Group Ltd | Clavulanic acid derivatives |
DE2862254D1 (en) * | 1977-12-02 | 1983-06-16 | Beecham Group Plc | A process for the preparation of ether derivatives of clavulanic acid |
EP0026044B1 (en) * | 1979-08-24 | 1983-06-08 | Beecham Group Plc | Amine salt of clavulanic acid, its preparation and use |
GB9702216D0 (en) * | 1997-02-04 | 1997-03-26 | Smithkline Beecham Plc | Novel product |
GB9702218D0 (en) * | 1997-02-04 | 1997-03-26 | Smithkline Beecham Plc | Novel product |
ATE187498T1 (de) * | 1997-03-24 | 1999-12-15 | Cipan Comp Ind Prod | Verfahren zur isolierung eines pharmazeutisch verträglichen alkalimetallsalzes der clavulansäure |
JPH11254368A (ja) * | 1998-03-12 | 1999-09-21 | Central Motor Co Ltd | 部材保持装置 |
EP1097238A1 (en) * | 1998-07-03 | 2001-05-09 | Dsm N.V. | Fermentation process to produce clavulanic acid at a low concentration of free amino acids |
PT102181A (pt) * | 1998-07-20 | 2000-01-31 | Dsm Nv | Processo melhorado para a producao de acido clavulanico |
AU2002211462A1 (en) * | 2000-10-05 | 2002-04-22 | Teva Gyogyszergyar Reszvenytarsasag | Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same |
US20040072815A1 (en) * | 2002-02-12 | 2004-04-15 | Koppel Gary A. | Antibiotic composition and method |
KR100461278B1 (ko) * | 2002-10-23 | 2004-12-10 | 현대자동차주식회사 | 용접 대상물의 위치규제 및 취출장치 |
EP3692159A1 (en) | 2017-10-02 | 2020-08-12 | Metabolic Explorer | Method for producing organic acid salts from fermentation broth |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE754693A (fr) * | 1969-08-12 | 1971-02-11 | Lilly Co Eli | Nouvel antibiotique et procede pour le preparer |
NZ177159A (en) * | 1974-04-20 | 1978-03-06 | Beecham Group Ltd | Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions |
JO984B1 (en) * | 1977-10-11 | 1979-12-01 | بيتشام غروب ليمتد | A dry pharmaceutical compound with a suitable dosage unit for oral administration |
-
1976
- 1976-02-06 IT IT7647988A patent/IT1059403B/it active Protection Beyond IP Right Term
- 1976-02-06 CH CH148776A patent/CH624956A5/de not_active IP Right Cessation
- 1976-02-06 JP JP51012156A patent/JPS51101994A/ja active Pending
- 1976-02-06 FI FI760285A patent/FI63580C/fi not_active IP Right Cessation
- 1976-02-06 ES ES76444948A patent/ES444948A1/es not_active Expired
- 1976-02-06 YU YU290/76A patent/YU40452B/xx unknown
- 1976-02-06 NL NL7601227A patent/NL7601227A/xx active Search and Examination
- 1976-02-06 IE IE245/76A patent/IE43790B1/en unknown
- 1976-02-06 DK DK49876AA patent/DK141099B/da not_active IP Right Cessation
- 1976-02-06 AU AU10891/76A patent/AU509313B2/en not_active Expired
- 1976-02-06 SE SE7601337A patent/SE421796B/xx not_active IP Right Cessation
- 1976-02-06 DE DE19762604697 patent/DE2604697A1/de active Granted
- 1976-02-06 FR FR7603281A patent/FR2368276A1/fr active Granted
- 1976-02-06 AT AT83476A patent/AT353409B/de not_active IP Right Cessation
- 1976-02-09 IT IT7648002A patent/IT1066098B/it active
-
1978
- 1978-03-20 US US05/888,496 patent/US4490294A/en not_active Expired - Lifetime
-
1980
- 1980-05-07 US US06/147,584 patent/US4490295A/en not_active Expired - Lifetime
- 1980-05-07 US US06/147,614 patent/US4367175A/en not_active Expired - Lifetime
-
1989
- 1989-02-27 JP JP1046384A patent/JPH0222281A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
SE7601337L (sv) | 1976-11-03 |
AU509313B2 (en) | 1980-05-08 |
CH624956A5 (de) | 1981-08-31 |
US4367175A (en) | 1983-01-04 |
SE421796B (sv) | 1982-02-01 |
FR2368276B1 (US07655688-20100202-C00109.png) | 1979-03-16 |
ES444948A1 (es) | 1977-08-16 |
DE2604697C2 (US07655688-20100202-C00109.png) | 1992-10-29 |
IE43790L (en) | 1976-08-07 |
DE2604697A1 (de) | 1976-08-19 |
JPS51101994A (US07655688-20100202-C00109.png) | 1976-09-08 |
DK141099B (da) | 1980-01-14 |
US4490294A (en) | 1984-12-25 |
IT1066098B (it) | 1985-03-04 |
IT1059403B (it) | 1982-05-31 |
AT353409B (de) | 1979-11-12 |
FI760285A (US07655688-20100202-C00109.png) | 1976-08-08 |
DK49876A (US07655688-20100202-C00109.png) | 1976-08-08 |
YU29076A (en) | 1982-08-31 |
AU1089176A (en) | 1977-08-11 |
FI63580C (fi) | 1983-07-11 |
JPH0222281A (ja) | 1990-01-25 |
ATA83476A (de) | 1979-04-15 |
FR2368276A1 (fr) | 1978-05-19 |
FI63580B (fi) | 1983-03-31 |
DK141099C (US07655688-20100202-C00109.png) | 1980-07-21 |
IE43790B1 (en) | 1981-06-03 |
NL7601227A (nl) | 1976-08-10 |
US4490295A (en) | 1984-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU61376A (en) | Process for the separation of lead | |
IL49064A (en) | Process for the manufacture of 7b-amino-cephem-3-ol-carboxylic acid compounds | |
YU40452B (en) | Process for the elimination of contaminating impurities from clavulinic acid | |
EG12080A (en) | Process for acid gas removal | |
ZA766351B (en) | Process for acid gas removal | |
PT65162A (en) | Process for the fluorodehydroxylation of alcohols | |
GB1483724A (en) | Process for the preparation of acetic acid | |
GB1547590A (en) | Process for the removal of acid gases | |
GB1547211A (en) | Removal of impurities from phosphoric acid | |
PH14111A (en) | Process for acid gas removal | |
PT64983A (en) | Process for the preparation of aminoacids | |
GB1556478A (en) | Process for the purification of phosphoric acid | |
IL47245A (en) | Process for the separation of gaseousmixtures | |
GB1551120A (en) | Process for the manufacture of 16-20-keto-steroids | |
GB1548020A (en) | Process for the manufacture of dithiocarbamic acid ester compounds | |
YU36540B (en) | Process for the crystallization of furctose | |
HU172484B (hu) | Sposob poluchenija 2-alkoksikarbonilamino-5/6/-fenil-sul'foniloksi-benzimidazolov s antgel'minticheskoj aktivnost'ju | |
GR58256B (en) | Process for the production of dioxyclavulanic acid | |
PT65821A (en) | Process for the preparation of novel d-homosteroids | |
YU307476A (en) | Process for the purification of esters | |
GB1541454A (en) | Process for the purification of pregnancy-specific -glycoprotein | |
ZA755930B (en) | Process for the manufacture of aluminiumchloride from ores | |
CH614695A5 (en) | Process for the preparation of alpha -amino-1-adamantylacetic acid | |
CS191967B2 (en) | Process for the separation of d-lysergic and d-isolysergic acid | |
CS179614B1 (en) | Process for the purification of diaminodiphenylsulphones |